Načítá se...
Long-term Follow-up of Psilocybin-facilitated Smoking Cessation
BACKGROUND: A recent open-label pilot study (N=15) found that two to three moderate to high doses (20 and 30 mg/70 kg) of the serotonin 2A receptor agonist psilocybin, in combination with cognitive behavioral therapy (CBT) for smoking cessation, resulted in substantially higher 6-month smoking absti...
Uloženo v:
| Vydáno v: | Am J Drug Alcohol Abuse |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5641975/ https://ncbi.nlm.nih.gov/pubmed/27441452 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/00952990.2016.1170135 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|